Compass Therapeutics Inc.

NASDAQ: CMPX · Real-Time Price · USD
2.60
-0.09 (-3.35%)
At close: Jun 26, 2025, 3:59 PM
2.73
5.20%
After-hours: Jun 26, 2025, 07:46 PM EDT

Compass Therapeutics Statistics

Share Statistics

Compass Therapeutics has 138.28M shares outstanding. The number of shares has increased by 0.5% in one year.

138.28M
0.5%
0.5%
73.68%
87.95M
84
0.01%

Short Selling Information

The latest short interest is 7.43M, so 5.4% of the outstanding shares have been sold short.

7.43M
5.4%
7.64%
13.63

Valuation Ratios

0
-4.87
0
0.9
0
0
0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Compass Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 14.96, with a Debt / Equity ratio of 0.05.

14.96
14.96
0.05
-0.12
-0.15
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$24,285.71
$-1,410,714.29
35
0.01
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 116.67% in the last 52 weeks. The beta is 1.22, so Compass Therapeutics's price volatility has been higher than the market average.

1.22
116.67%
2.11
2.08
63.51
1,437,456

Income Statement

In the last 12 months, Compass Therapeutics had revenue of 850K and earned -49.38M in profits. Earnings per share was 0.

850K
850K
-56.63M
-49.38M
-54.87M
-56.63M
0
Full Income Statement

Balance Sheet

The company has 43.48M in cash and 6.63M in debt, giving a net cash position of 36.85M.

43.48M
6.63M
36.85M
-364.68M
131.45M
109.25M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -44.85M and capital expenditures -44K, giving a free cash flow of -44.9M.

-44.85M
-44K
-44.9M
0
Full Cash Flow Statement

Margins

Gross margin is 100%, with operating and profit margins of -6661.76% and -5808.82%.

100%
-6661.76%
-5808.82%
-5808.82%
-6455.53%
-6661.76%
-5282.24%

Dividends & Yields

CMPX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for CMPX is $8, which is 207.7% higher than the current price. The consensus rating is "Buy".

$8
207.7%
Buy
8
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
-100%
n/a
n/a

Scores

5.34
3